Leading Peptide therapeutic development portfolio.

Led a global team based in the JNJ Innovation Centers to deliver high value external assets to the DePuy Synthes portfolio. This includes strategic innovation portfolio leadership across the global orthopedic franchise and prioritizing key technologies with an emphasis on cross-franchise and cross-sector platform solutions. Led the Philadelphia JPOD startup Incubator. Created the DePuy Synthes Software Enabled Surgery Platform including the Orthotaxy Robotics Opportunity.

Created and managed a business innovation team. This consisted of leadership of four distinct businesses as well as cross franchise and cross sector work at Johnson and Johnson. This included :1) The DePuy Synthes Select business, a new disruptive high growth commercial model leveraging the greater DePuy Synthes portfolio in the Ambulatory Surgery Centers. Included Sales, Sales Operations, Marketing and Product Development. Also created business technology platforms such as SalesForce.com Customer Relations Management, and E-Commerce Portal, and Virtual Technical Support.2) The Geriatric Fracture Program, a care pathway standardization program for elderly fracture patients that decreased mortality, morbidity and length of stay making the hospital more efficient and the stay less costly. This was implemented in 150+ hospitals to date. This was part of the DePuy Synthes Advantage umbrella of programs and services. 3) The rapidly growing Global Veterinary Surgery business, the market leader in Veterinary Orthopedics ad innovation. This included Product Development, Marketing, Sales, Sales Operations, Education and Training.4) Commercial Synergies, a function that leveraged DePuy Synthes adjacent portfolios and sales forces to create immediate selling and promotional synergies resulting in significant incremental growth Member of the Trauma Management Board ($2.5B global business), Global Marketing Council, Commercial Innovation Council, Triple Aim Acceleration Team, Berkeley Innovation Forum, Global strategic planning & market intelligence. Managed a team that optimized and expanded current businesses while investigating and assessing others--commercial business unit incubation. Created a portfolio management tool that assessed and prioritized projects and helped assign global resources, enabling optimal business investments driving growth. Led the Trauma Integration and post merger strategy.

Global Position for Trauma Division leading New Business Development, Strategic Planning, Portfolio Management Business Liaison with Venture Funds, Private Equity, Investment Bankers, University Technology Transfer offices and Orthopedic Innovators.Lead downstream marketing, training and event planning as part of the Program Management Function.

This is a general management role for a new Synthes Business Unit focused on Sports Medicine and innovative soft tissue solutions. Responsibilities included evaluating unmet clinical needs and business opportunities, developing a business plan that includes portfolio and channel development and organizing all support services. It involves working with internal and external stakeholders and partners worldwide to build a new business. This involved leadership of Business Development in the US and EU, R&D, Product Development, Finance, and Strategic Marketing.

Member of the Executive Management Team of a $60M Spine company. Developed and implemented the new corporate vision, branding and worldwide relaunch. Led multiple product launches and re-established double digit US growth. Worked closely with Board members of Healthpoint Capital. 50% of time spent in Europe.Led the clinical studies and scientific communications Team. Led two major clinical trials and prepared two IDE/PMAs. Lead strategic planning, portfolio management, new business development. All upstream and downstream marketing functions. Built global surgeon advisory boards. Led Professional Education and Sales Training including the Scient'x Academy. Led the surgeon compliance function along with annual needs assessments, and corporate compliance policy.

Led Medical Education and Training Team. Team trained over 2000 surgeons and 500 reps per year. Assemble global surgeon advisory boards, faculty, researchers, and product developers.Lead clinical studies and scientific communications function.Negotiated lead sponsorships with all major extremity societies worldwide.Built and maintained the surgeon compliance policy.

Led long term strategic development, portfolio strategy and executed the largest business acquisition in company history (Link NA). Led the diligence and integration. Built the go-to-market strategy for the Ankle business, integrating ankle arthroplasty with the Nail, External fixation and Internal Fixation platforms for a "total anatomic solution' offering.Executive of the year 2006.

Part of a small group that created the Small Bone Team at Arthrex. Responsibilities included portfolio planning, product management, cross-functional project leadership, and new product launches.Developed surgeon advisory teams around education, R&D, and research. Led surgeon and sales training and education.